Researcher
Matteo Riva
- Disciplines:Oncology, Immunology
Affiliations
- Laboratory for Tumor Immunology and Immunotherapy (Division)
Member
From1 Jun 2019 → Today - Department of Microbiology, Immunology and Transplantation (Department)
Member
From1 May 2016 → 31 May 2019 - Laboratory of Clinical and Epidemiological Virology (Rega Institute) (Division)
Member
From1 Jun 2015 → 30 Apr 2016
Projects
1 - 3 of 3
- Developing combinatorial immunotherapy for glioblastomaFrom7 Nov 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Preclinical evaluation of novel radionuclide therapies in different cancer modelsFrom8 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Characterization and analysis of in vivo intracranial models for glioblastomaFrom1 Dec 2019 → 31 Mar 2022Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 37
- Radiation dose-escalation and dose-fractionation modulate the immune microenvironment, cancer stem cells and vasculature in experimental high-grade gliomas(2023)
Authors: Matteo Riva, Roxanne Wouters, David Nittner, Jolien Ceusters, Edmond Sterpin, Uwe Himmelreich, Willy Gsell, Marc Van Ranst, An Coosemans
Pages: 55 - 65 - Selective Cerebrospinal Fluid Hypothermia: Bioengineering Development and In Vivo Study of an Intraventricular Cooling Device (V-COOL)(2022)
Authors: Matteo Riva
Pages: 1942 - 1950 - Liquid Biopsy in Glioblastoma(2022)
Authors: Matteo Riva, An Coosemans
- CryptoCEST: A promising tool for spatially resolved identification of fungal brain lesions and their differentiation from brain tumors with MRI(2021)
Authors: Liesbeth Vanherp, Matteo Riva, An Coosemans, Katrien Lagrou, Willy Gsell, Greetje Vande Velde, Uwe Himmelreich
- Type of chemotherapy has substantial effects on the immune system in ovarian cancer(2021)
Authors: Ann Vankerckhoven, Thaïs Baert, Matteo Riva, Christine De Bruyn, Jolien Ceusters, Ignace Vergote, An Coosemans
- Radiotherapy, Temozolomide, and Antiprogrammed Cell Death Protein 1 Treatments Modulate the Immune Microenvironment in Experimental High-Grade Glioma(2021)
Authors: Matteo Riva, Roxanne Wouters, Edmond Sterpin, Uwe Himmelreich, Willy Gsell, Marc Van Ranst, An Coosemans
Pages: E205 - E215 - Immunocompetent Mouse Models in the Search for Effective Immunotherapy in Glioblastoma(2021)
Authors: Roxanne Wouters, Sien Bevers, Matteo Riva, Frederik De Smet, An Coosemans
- Clinical, radiological and molecular characterization of intramedullary astrocytomas(2020)
Authors: Matteo Riva
- Long-lived tumor-associated macrophages in glioma(2020)
Authors: Matteo Riva, Holger Gerhardt
- Immune-driven therapeutic combinations in a new mouse model of high-grade glioma(2019)
Authors: Matteo Riva, An Coosemans, Marc Van Ranst